Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal

Simran S Mangat1, B Ramasamy, Som Prasad

  • 1Wirral University Hospital Trust. simranmangat36@hotmail.com

Seminars in Ophthalmology
|February 1, 2011
PubMed

Insights

This study presents a case series of four patients with choroidal neovascularization (CNVM) due to punctal ઇન્ફ્લેમેશન (PIC). Treatments included anti-VEGF therapy alone or with photodynamic therapy (PDT), offering extended follow-up data.

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Vascular Biology

Background:

  • Choroidal neovascularization (CNVM) secondary to punctal ઇન્ફ્લેમેશન (PIC) is a rare condition.
  • Limited long-term follow-up data exists for treatment outcomes in these cases.

Observation:

  • A case series of four patients with PIC-induced CNVM was retrospectively analyzed.
  • Patients received treatment with anti-vascular endothelial growth factor (VEGF) agents, with or without photodynamic therapy (PDT).

Findings:

  • The study provides long-term follow-up data, ranging from 3 to 28 months, for patients treated for PIC-related CNVM.
  • Outcomes suggest potential efficacy of anti-VEGF therapy, alone or combined with PDT, in managing this condition.

Implications:

  • This research contributes valuable long-term clinical data for a poorly understood condition.
  • Findings may inform future treatment strategies and clinical trial designs for PIC-induced CNVM.